BLFS Tiesioginiai signalai | Didinkite pelną su Getagraph.com

PARDAVIMAS 110731 min ago

@ $18.00

Išleistas: 14 vas. 2024 @ 16:30

Grąža: -2.56%

Ankstesnis signalas: vas. 13 - 16:30

Ankstesnis signalas: Pirkimas

Grąža: 5.45 %

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 23:00):

Stats
Šios dienos apimtis	423 586
Vidutinė apimtis	382 321
Rinkos kapitalizacija	794.56M
EPS	$0 ( 2024-02-29 )
Kita pelno data	( $-0.260 ) 2024-05-08
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-11.54
ATR14	$0.0280 (0.16%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-18	Aebersold Sarah	Sell	348	Common Stock
2024-04-22	Aebersold Sarah	Sell	410	Common Stock
2024-04-18	Foster Karen A.	Sell	481	Common Stock
2024-04-18	Mathew Aby J.	Sell	584	Common Stock
2024-04-18	Berard Todd	Sell	332	Common Stock

INSIDER POWER
74.00
Last 100 transactions
Buy: 1 173 359 \| Sell: 163 974

Tūris Koreliacija

Ilgas: -0.11 (neutral)

Trumpas: 0.75 (moderate)

Signal:(64.404) Neutral

Biolife Solutions Inc Koreliacija

10 Labiausiai teigiamai susiję koreliacijos
COLL	0.888
CTMX	0.873
BCDA	0.867
TNXP	0.85
FPAY	0.849
ANGI	0.847
DADA	0.841
GNSS	0.838
AIP	0.836
ZS	0.836

10 Labiausiai neigiamai susiję koreliacijos
MASI	-0.882
SWBI	-0.826
AMRB	-0.824
AXON	-0.818
NETE	-0.807
IPAR	-0.806
IBOC	-0.805

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Biolife Solutions Inc Koreliacija - Valiuta/Žaliavos

-0.66
( moderate negative )

-0.87
( strong negative )

-0.56
( weak negative )

-0.36
( neutral )

0.74
( moderate )

Biolife Solutions Inc Finansinės ataskaitos

Annual	2023
Pajamos:	$143.27M
Bruto pelnas:	$41.57M (29.02 %)
EPS:	$-1.520

FY	2023
Pajamos:	$143.27M
Bruto pelnas:	$41.57M (29.02 %)
EPS:	$-1.520

FY	2022
Pajamos:	$161.76M
Bruto pelnas:	$53.82M (33.27 %)
EPS:	$-3.29

FY	2021
Pajamos:	$119.16M
Bruto pelnas:	$37.05M (31.09 %)
EPS:	$-0.220

Financial Reports:

No articles found.

Biolife Solutions Inc

BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It offers proprietary biopreservation media products, including HypoThermosol FRS and CryoStor that are formulated to mitigate preservation-induced, delayed-onset cell damage and death; and the ThawSTAR line that includes automated vial and cryobag thawing products that control the heat and timing of the thawing process of biologic materials. The company also provides evo shipping containers that are cloud-connected passive storage and transport containers for temperature-sensitive biologics and pharmaceuticals; liquid nitrogen laboratory freezers, cryogenic equipment, and accessories; and biological and pharmaceutical storage services. It markets and sells its products directly, as well as through third party distributors. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington.